Cameco Balance Sheet Health
Financial Health criteria checks 4/6
Cameco has a total shareholder equity of CA$6.1B and total debt of CA$2.0B, which brings its debt-to-equity ratio to 32.1%. Its total assets and total liabilities are CA$9.9B and CA$3.8B respectively. Cameco's EBIT is CA$245.4M making its interest coverage ratio -4.2. It has cash and short-term investments of CA$566.8M.
Key information
32.1%
Debt to equity ratio
CA$1.96b
Debt
| Interest coverage ratio | -4.2x |
| Cash | CA$566.81m |
| Equity | CA$6.09b |
| Total liabilities | CA$3.84b |
| Total assets | CA$9.93b |
Recent financial health updates
No updates
Recent updates
Cameco: Upgrading To 'Buy' After Pullback, Strong Uranium Market
Mar 18Cameco Earnings: Outlook For 2024 Is Strong
Feb 12Cameco: Uranium Prices Are White Hot
Jan 11Cameco: Time To Book Some Profits
Dec 08Cameco's Promising Outlook: Riding The Wave Of The Uranium Resurgence
Oct 31Cameco: Nuclear's Bright Future Is Already Priced In
Sep 20Cameco: Bright Near-Term Outlook With Improving Market Fundamentals, 20% Upside
Sep 12Got Uranium? Why Cameco Remains Unstoppable
Sep 03Cameco: Keeps Adding To Its Contract Portfolio (Rating Downgrade)
Aug 18Cameco: First Half Results Robust, But The Stock Is Richly Priced
Aug 03Cameco: Digging For Precious Uranium Ore
Jul 19Cameco: Uranium Price In The Short Term, Nuclear Renaissance In The Long Term (Rating Upgrade)
Jun 20Cameco: Riding The Wave Of Positive Momentum In The Uranium Sector
Jun 13Cameco Q4 2022 Earnings Preview
Feb 08Cameco Is Now Well Positioned To Become A Significant Nuclear Supplier
Feb 02Cameco: 3 Catalysts For 2023
Jan 26Cameco: A Turnaround Is En Route
Jan 17Cameco: Changing Direction, Complicating The Bull Case
Nov 15Cameco ext5ends uranium supply contract with China Nuclear International
Nov 07Cameco Q3 2022 Earnings Preview
Oct 26Cameco: Westinghouse Deal Brings Value
Oct 18Cameco's Contract Portfolio Is Positioned To Benefit Investors
Oct 06Cameco files for $1.5B securities offering
Sep 27Cameco: Nuclear Now Moving Higher, Cheaply Valued
Sep 12Cameco: Great Outlook But Too Much Of Future Growth Is Already Priced In
Aug 24Cameco: Uranium Stages A Comeback, The Market Starts To Notice
Aug 01Cameco Q2 2022 Earnings Preview
Jul 26Cameco: A Conservative Choice In A Uranium Market With Improving Fundamentals
Jul 18Cameco: Uranium For Your Portfolio, Key Development On The Cards
Jun 08Cameco: Increases 2022 Revenue Guidance, Interesting Nuclear Opportunity
May 05Cameco: Nuclear Opportunity, Dividend To Increase 50% In 2022
Apr 04Cameco: Why I Think This Uranium Front-Runner Is Going Further Up
Mar 16Cameco: Contract Mix And Macro Risk Hurt The Stock
Mar 05Cameco Is Restarting McArthur River But I'm Still Bearish
Feb 12Kazatomprom: Major Uranium Sector Player, More Attractive Than Cameco
Jan 21Cameco Stock: High Uranium Prices Are Starting To Bite
Nov 23Cameco: Get Ready For Nuclear Energy Renaissance
Oct 19Financial Position Analysis
Short Term Liabilities: CCJ's short term assets (CA$1.8B) exceed its short term liabilities (CA$1.2B).
Long Term Liabilities: CCJ's short term assets (CA$1.8B) do not cover its long term liabilities (CA$2.7B).
Debt to Equity History and Analysis
Debt Level: CCJ's net debt to equity ratio (22.8%) is considered satisfactory.
Reducing Debt: CCJ's debt to equity ratio has increased from 30% to 32.1% over the past 5 years.
Debt Coverage: CCJ's debt is well covered by operating cash flow (35.2%).
Interest Coverage: CCJ earns more interest than it pays, so coverage of interest payments is not a concern.